Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,666.69
(
-0.74%
)
US TECH 100
23,961.20
(
-0.71%
)
Dow Jones
46,564.47
(
-0.91%
)
Brent Oil
105.68
(
4.99%
)
Bitcoin
71,277.83
(
-3.60%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Dub Narcotic post# 105031

Friday, 09/24/2010 11:18:17 PM

Friday, September 24, 2010 11:18:17 PM

Post# of 257253

Cladribine doesn't win on efficacy, safety or convenience. I'm not sure where the market is. Second and third-line salvage therapy, I suppose.

Cladribine’s best shot is in the second-line needle-phobic setting :- )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up